论文部分内容阅读
Objective: Summary of the latest progress of bevacizumab combined with chemotherapy in the treatment of lung cancer in recent 4 years.
New progress in the study of bevacizumab combined with chemotherapy in the treatment of lung cancer
【摘 要】
：
Objective: Summary of the latest progress of bevacizumab combined with chemotherapy in the treatment of lung cancer in recent 4 years.
【机 构】
：
310053 浙江省杭州市,浙江中医药大学第一临床医学院 浙江中医药大学附属第一医院
【出 处】
：
第四届广州国际肿瘤学会议
【发表日期】
：
2015年7期
其他文献
New risk factorsand new tendency for central nervous system relapsein patients with diffuse large B-
Background:Central nervous system(CNS) relapse in patients with diffuse large B cell lymphoma occurs uncommonly,but is always fatal.Detection of reliable risk factors for CNS relapse is still an open
会议
ARF couples with p53 in a canonical signaling pathway for tumor suppression function topromote cellular senescence in cells.
Evaluation the efficacy of radiotherapy for patients with locally advanced or postoperatively recurr
Objective: Patients with locally advanced or postoperatively recurrent gastric cancer usually survived poor with traditional salvage chemotherapy.
CXCL2/MIF/CXCR2 axis-mediated myeloid-derived suppressor cells recruitment regulate tumor progressio
Myeloid-derived suppressor cell(MDSC)expansion in tumor-bearing host is correlated with immune suppression; however its related mechanism is still largely blurred.
会议
Exosomaldelivery of miR-24-3pmediates T-cell dysfunction viarepressing FGF11 and correlates with pro
Tumor-derived exosomes(T-EXO)carry a broad range of cargo,including proteins,microRNAs,mRNAs,and DNA fragments,to transfer signaling between tumor cell and immune cells.
会议
Introduction: Elevated c-FLIP levels which are observed in many cancers,were also shown to correlate with a more aggressive tumor.
Aberrant AKT activation is prevalent across multiple human cancer lineages,providing an important target for therapy.Phosphorylation plays critical roles in AKT stability and activation.
Validation of progression-free survival as a surrogate endpoint for overall survival in malignant me
To investigate whether progression-free survival(PFS)can be considered a surrogate endpoint for overall survival(OS)in malignant mesothelioma both at the patient and trial level.
会议
Non-invasive fibrosis indexes in predicting acute liver function deterioration after Transcatheter a
Background Transcatheter arterial chemoembolization(TACE)is the first-line therapy for unresectable Hepatocellular Carcinoma(HCC),acute liver function deterioration(ALFD)after operation is a severe co
Efficacy and security of treatment by bevacizumab and platinum-based on chemotherapy on advanced non
Objective: To evaluate efficacy and security of treatment by bevacizumab and platinum on advanced nonsmall-cell lung cancer.